Post-COVID Cancer Screenings Up but Racial Divide Remains
Cancer screening tests rebounded in the last quarter of 2020, following a dramatic decline in the first months of the COVID-19 pandemic.
Read MorePosted by Chris Wolski | Jul 9, 2021 | Cancer |
Cancer screening tests rebounded in the last quarter of 2020, following a dramatic decline in the first months of the COVID-19 pandemic.
Read MorePosted by Chris Wolski | Jul 2, 2021 | Diagnostic Technologies |
University of Michigan researchers have found evidence suggesting that preoperative testing is often unnecessary for low-risk surgeries.
Read MorePosted by Melanie Hamilton-Basich | Jun 22, 2021 | Digital Pathology |
Epredia has been appointed as a global distribution partner for Aiforia’s portfolio of preclinical and clinical pathology tools, including segment exclusivity for distribution in the United States.
Read MorePosted by Melanie Hamilton-Basich | May 24, 2021 | Lung Cancer |
The new findings show the Percepta Nasal Swab, a first-of-its-kind genomic test, accurately classifies lung cancer risk in current or former smokers with lung nodules so that those with benign nodules may safely avoid unnecessary additional procedures.
Read MorePosted by Chris Wolski | May 12, 2021 | Covid 19 |
To identify and treat COVID-19 patients at an early stage, predictive biomarkers need to be identified; researchers have discovered one.
Read More